z-logo
Premium
Effect of alprazolam on digoxin kinetics and creatinine clearance
Author(s) -
Ochs Hermann R,
Greenblatt David J,
VerburgOchs Birgitt
Publication year - 1985
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1985.230
Subject(s) - alprazolam , digoxin , creatinine , renal function , pharmacology , medicine , chemistry , heart failure , psychiatry , anxiety
Eight healthy men received a single, 1.25 mg dose of digoxin on two occasions, once in an otherwise drug‐free control state and again while concurrently receiving alprazolam, 1.5 mg/day. There was no significant difference between control and alprazolam conditions in digoxin volume of distribution (11.0 vs. 11.2 L/kg), elimination t ½ (46 vs. 41 hours), or total clearance from serum (2.8 vs. 3.6 ml/min/kg). Alprazolam coadministration slightly reduced mean 96‐hour urinary excretion of digoxin (37.6% vs. 30.9% of dose; P < 0.01), but there was no significant difference between treatment conditions in projected total cumulative excretion of digoxin (45.2% vs. 40.9% of dose) or in renal clearance of digoxin (1.23 vs. 1.44 ml/min/kg). Creatinine clearance also did not differ between the control and alprazolam conditions (164 vs. 142 ml/min). Thus therapeutic doses of alprazolam do not significantly alter digoxin clearance in healthy man. Clinical Pharmacology and Therapeutics (1985) 38, 595–598; doi: 10.1038/clpt.1985.230

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom